Basis for Variability of Response to Anti-Rheumatic Drugs : Proceeding of a Satellite Meeting of the Xth International Congress of Pharmacology held in Sydney, Australia August 20-22, 1987 (Agents and Actions Supplements .24) / Brooks, P.

Basis for Variability of Response to Anti-Rheumatic Drugs : Proceeding of a Satellite Meeting of the Xth International Congress of Pharmacology held in Sydney, Australia August 20-22, 1987 (Agents and Actions Supplements .24) （Softcover reprint of the original 1st ed. 1988. 2011. xvi, 268 S. XVI,）

個数：

Basis for Variability of Response to Anti-Rheumatic Drugs : Proceeding of a Satellite Meeting of the Xth International Congress of Pharmacology held in Sydney, Australia August 20-22, 1987 (Agents and Actions Supplements .24) （Softcover reprint of the original 1st ed. 1988. 2011. xvi, 268 S. XVI,）

Brooks, P.

ドイツ（DK）から取り寄せる

ウェブストア価格 ¥13,920（本体¥12,655）
SPRINGER, BASEL; BIRKHÄUSER BASEL; BIRKHÄUSER（2011発売）
外貨定価 EUR 53.49
ポイント 126pt

在庫がございません。海外の書籍取次会社を通じて出版社等からお取り寄せいたします。
通常6～9週間ほどで発送の見込みですが、商品によってはさらに時間がかかることもございます。
【重要ご説明事項】
1. 納期遅延や、ご入手不能となる場合がございます。
2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
3. 美品のご指定は承りかねます。

●3Dセキュア導入とクレジットカードによるお支払いについて

アメリカ（US）から取り寄せる

ウェブストア価格 ¥12,155（本体¥11,050）
SPRINGER, BASEL; BIRKHÄUSER BASEL; BIRKHÄUSER（2011発売）
外貨定価 US$ 54.99
ポイント 110pt

オンデマンド(OD/POD)版です。キャンセルは承れません。

≪洋書のご注文について≫ 「海外取次在庫あり」「国内在庫僅少」および「国内仕入れ先からお取り寄せいたします」表示の商品でもクリスマス前(12/20～12/25)および年末年始までにお届けできないことがございます。あらかじめご了承ください。

【入荷遅延について】
世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。

◆画像の表紙や帯等は実物とは異なる場合があります。

◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
また、洋書販売価格は、ご注文確定時点での日本円価格となります。
ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。

製本 Paperback:紙装版/ペーパーバック版／ページ数 288 p.
言語 ENG
商品コード 9783034899314

Full Description

Since the rheumatic diseases are among the most prevalent of conditions, the anti-rheumatic drugs make up one of the largest groups of drugs prescribed. They vary from the non-steroidal anti-inflammatory drugs through to the complex imrnunomodulators. There are significant differences between these groups of drugs as regards their mechanism of action and within each spectrum of adverse reactions, yet there is also some overlap. class there are also subtle individual differences between the drugs despite a sharing of the basic mechanisms of action and range of side effects. It is this individual variation and, in particular, the individual reaction of the patient to the drug that we attempted to address at this symposium. The first symposium on Individual Variation in Response to Non Steroidal Anti-inflammatory Drugs was held at Leura, New South Wales, Australia as a satellite symposium to the XVI International Congress of Rheumatology in August, 1985. Following a successful meeting, proceedings of which were published in a supplement to Agents and Actions (Suppl. 17, 1986), it was decided to organise a second symposium as a satellite meeting of the International Congressof Pharmacology Meeting in Sydney, August, 1987. The meeting was held at the Manly Pacific and focused on variability in response to anti-rheumatic drugs in general rather than just concentrating on the non-steroidal drugs.

Inflammation 1987 — An Overview.- Screening for Anti-Rheumatic Activity.- Screening for Adverse Reactions from Anti-Rheumatic Drugs.- The Effects of Anti-Inflammatory and Anti-Rheumatic Drugs on Phagocytic Cell Function.- Actions of Non-Steroidal Anti-Inflammatory Drugs on the Functions of Lymphocytes.- Kinetics of Non-Steroidal Anti-Inflammatory Drugs in Synovial Fluid.- The Contribution of Enantiomers to Variability in Response to Anti-Inflammatory Drugs.- Epidemiological Assessment of the Association between NSAIDs and Peptic Ulcer Complications.- Renal Side Effects of Non-Steroidal Anti-Inflammatory Drugs.- Design of Trials to Study Variability in Response: Statistical Aspects.- Aspects of the Clinical Trials of Slow Acting Anti-Rheumatic Drugs.- Design of Trials to Study Variability in Response: Clinical Aspects - End Points.- Pharmacokinetics and Cellular Uptake of 4-Aminoquinolone Anti-Malarials.- Myocrisin.- Auranofin in Rheumatoid Arthritis: What Variable Could Affect the Clinical Response.- Mechanisms of Gold Resistance.- Variable Responses to Gold (1) - Thiolates (Chrysotherapy) in Two Models of Rat Polyarthritis.- The Clinical Efficacy of Sulphasalazine in Rheumatic Disease.- D-Penicillamine Pharmacokinetics and Action.- Pro-Inflammatory and Catabolic Effects of Interleukin-1 and Their Antagonism by Glucocorticoids.- Variability of Methotrexate Pharmacokinetics and Pharmacodynamics.- Ciclosporin in Rheumatoid Arthritis: A Review.- Immunomodulators.